拥有近30年历史的知名老牌连锁超市巨头人人乐，即将告别A股。 5月7日晚， *ST人乐（即人人乐，002336. SZ ）发布公告称，公司于2025年5月6日收到 深圳证券交易所下发的《终止上市事先告知书》， 深圳证券交易所拟决定终止公司股票上 市交易 。 作为一家成立于1996年的老牌零售企业，人人乐曾经是深圳零售企业的旗帜之一， 曾在深 圳与沃尔玛、家乐福"硬碰硬"。2010年上市后，人人乐 曾连续多年营收过百亿元，门店遍 布全国。然而，近年来其业绩持续下滑，连续多年亏损，如今已是资不抵债，令人唏嘘。 人人乐：收到《终止上市事先告知书》 连续2年净资产为负，股票已停牌 公告显示，人人乐（以下简称"公司"）于2025年5月6日收到深圳证券交易所下发的《终止 上市事先告知书》（公司部函[2025]第197号），深圳证券交易所拟决定终止公司股票上市 图片来源：视觉中国（资料图） 交易。现将有关内容公告如下： 目前，人人乐股票已停牌，停牌前股价连续多日跌停，年内已跌超40%，总市值还剩16.24 亿元。 "2024年4月22日， 因你公司2023年度经审计的净资产为-3.87亿元，你公司股票交易被 实施退市风险警 ...

Core Viewpoint - Novo Nordisk continues to demonstrate strong performance growth in Q1 2025, driven by its star product GLP-1 drugs, particularly semaglutide, which has surpassed Merck's Keytruda in global sales [1][4]. Financial Performance - In Q1 2025, Novo Nordisk reported a net profit of 29.034 billion Danish Krone (approximately 4.4 billion USD), a 14% increase year-over-year, exceeding analyst expectations [2]. - Total revenue for Q1 2025 reached 78.087 billion Danish Krone (approximately 11.216 billion USD), reflecting an 18% year-over-year growth [2][3]. - The U.S. market contributed 44.316 billion Danish Krone (approximately 6.365 billion USD) in revenue, a 17% increase, while the Chinese market generated 5.622 billion Danish Krone (approximately 0.807 billion USD), with a 22% growth [2]. Product Performance - Semaglutide sales reached 55.776 billion Danish Krone (approximately 8.484 billion USD), accounting for about 71% of Novo Nordisk's total revenue [3]. - Ozempic generated sales of 32.721 billion Danish Krone (approximately 4.9 billion USD), up 18% year-over-year, while Wegovy saw a remarkable 83% increase in sales to 17.360 billion Danish Krone (approximately 2.593 billion USD) [2][3]. - Rybelsus sales were 5.695 billion Danish Krone (approximately 0.818 billion USD), reflecting a 14% growth [2][3]. Market Position - In Q1 2025, semaglutide's sales surpassed Merck's Keytruda, which reported global sales of 7.2 billion USD, marking a 4% year-over-year increase [4][7]. - The demand for Wegovy is expected to face challenges due to competition from generic drug manufacturers, prompting Novo Nordisk to lower its annual sales growth forecast [8][9]. Future Outlook - Novo Nordisk has revised its full-year sales growth forecast to between 13% and 21%, down from the previous estimate of 16% to 24% [9]. - The company emphasizes the potential market for obesity treatment, noting that approximately 1 billion people globally suffer from obesity, yet only a few million are receiving treatment [9].

Group 1: US-China Trade Relations - The recent US-China high-level talks are a response to unilateral tariff measures imposed by the US, which have severely impacted bilateral trade relations and disrupted the international economic order [2][3] - China emphasizes its commitment to defending its development interests and maintaining international fairness and justice, stating that any dialogue must be based on mutual respect and benefit [3] - China is open to negotiations but will not compromise on its principles or allow coercive tactics from the US [3] Group 2: Skechers Privatization Announcement - Skechers announced its decision to go private on May 5, which has caused significant market reactions, as it is the third-largest athletic shoe retailer globally [6] - The company reported nearly $9 billion in sales for 2024, a 12% year-over-year increase, but faced a 3% decline in sales in the Asia-Pacific region, primarily due to poor performance in China [6] - A coalition of 76 footwear companies, including Skechers, has petitioned the White House for tariff exemptions, citing the survival threat posed by current tariff policies [6] Group 3: Domestic Gold Prices - Domestic gold jewelry prices have surpassed 1,000 yuan per gram due to rising international gold prices, with major retailers adjusting their prices accordingly [9] Group 4: Domestic Tourism Growth - During the recent May Day holiday, domestic travel reached 314 million trips, marking a 6.4% year-over-year increase, with total spending amounting to approximately 180.27 billion yuan, an 8.0% increase from the previous year [11][12]

Core Viewpoint - The article discusses the challenges faced by the well-known brand "胖东来" (Pang Dong Lai), including a marketing controversy with a similarly named competitor "胖都来" (Pang Dou Lai) and negative publicity from self-media sources [1][5]. Group 1: Marketing Controversy - The opening of "胖都来" in Zhejiang has sparked controversy due to its name being similar to "胖东来," leading to confusion among consumers [3][4]. - Several celebrities recorded congratulatory videos for "胖都来," but these were later removed following public backlash and a formal apology from actor Zhao Liang, clarifying no commercial ties with "胖都来" [4][6]. - Legal experts suggest that "胖都来" may be infringing on "胖东来"'s trademark rights, as the names are similar and could mislead consumers [4][6]. Group 2: Self-Media Criticism - Self-media has accused "胖东来" of exploiting low-cost jade to make excessive profits, leading to public criticism of its product quality [5][6]. - In response, "胖东来" founder 于东来 (Yu Dong Lai) invited critics to visit and investigate the company, emphasizing transparency [6][7]. - The local market regulatory authority found no violations during their inspection of "胖东来," and actions were taken against the self-media account that spread false information [7][8]. Group 3: Broader Implications - The article highlights the challenges faced by prominent companies in the self-media era, where misinformation can spread rapidly and harm reputations [8][10]. - It calls for stricter regulations and accountability from platforms hosting self-media content to prevent the spread of false information and protect businesses [10][11]. - The need for improved media literacy among the public is emphasized to combat the spread of rumors and ensure fair market competition [11].

5月6日，话题#刘强东回应凑鸡蛋上大学#冲上热搜。5月5日，中国人民大学校友会官微发 布刘强东相关视频，刘强东谈及"凑鸡蛋上大学"等话题。 在视频中，刘强东称："当时是因为家里面都很穷，所以村里面最好的也就是鸡蛋了。带了 76个鸡蛋，然后到了人大。前面一星期为了省钱呢，也就没怎么去食堂，就全部吃鸡蛋一 天三餐。" 图片来源：中国人民大学校友会官微视频截图 刘强东还表示："人大呢，老实说，在这个学校里面度过了，我可以说是人生中最重要的四 年。最早创业也是在人大，可以说是塑造我的价值观最重要的四年。" 每经注意到，该视频曾于2018年发布于中国人民大学官方微信。 当时刘强东在接受采访时表示： 图片来源：中国人民大学校友会官微视频截图 社"四个大字。就这样，我一个人坐上火车，背了三个大袋到北京上大学。 当时我带的最贵重的东西就是老乡们东拼西凑攒的500块钱，我要靠着那500块钱在北京生 存4年。我当时还背了76个茶叶蛋，也是老乡们给的，茶叶蛋是那个年代村里面最好的营养 品。 值得注意的是，今年1月，刘强东的老家——江苏宿迁光明村火上了热搜。今年1月8日，刘 强东为光明村乡亲发年货，从吃、穿到用的物品共三十多件，为村 ...

Core Viewpoint - Gucci, once a leading luxury brand, is facing significant challenges in the market, evidenced by store closures and declining sales figures, particularly in China [2][5]. Group 1: Store Closures and Market Strategy - In February, Gucci closed two stores in Shanghai's Jing'an Temple area, sparking discussions about the brand's declining popularity [2]. - The brand has also closed stores in various cities including Taiyuan, Shenyang, Hong Kong, Dalian, and Fuzhou, indicating a strategic contraction in its operations [2]. - Gucci's official response to inquiries about future closures was that there is currently no related information [2]. Group 2: Financial Performance - Kering Group reported a 14% decline in sales to €3.883 billion for Q1 2025, with Gucci's revenue falling to €1.57 billion, a 25% drop in comparable sales [5]. - Gucci's Q1 revenue was below analyst expectations of €1.62 billion, and same-store sales fell more than anticipated [5]. - The brand has experienced continuous quarterly declines in sales since last year, with year-over-year drops of 21%, 20%, 25%, and 24% [5]. Group 3: Brand Perception and Consumer Trends - Gucci's brand image has suffered, with consumers perceiving its designs as outdated and overly flashy compared to the current trend of understated luxury [10]. - The last major hit product from Gucci was the 1955 series in 2019, and since then, the brand has struggled to create buzzworthy items [10]. - The brand's attempts to appeal to younger consumers have been ineffective, leading to a lack of clear brand identity [10]. Group 4: Challenges in the Second-Hand Market - Gucci products have seen significant depreciation in the second-hand market, with items originally priced over €20,000 selling for only €2,000 to €6,000 [14]. - The average resale price of popular Gucci items is only 40% of their retail price, indicating a lack of perceived value among consumers [14]. - Factors contributing to this depreciation include inconsistent pricing strategies and the availability of discounted products through outlets [15]. Group 5: Recommendations for Improvement - To revitalize its brand, Gucci needs to focus on re-establishing its luxury image, enhancing product innovation, and improving operational efficiency through digital means [17]. - The brand should also prioritize targeted marketing strategies to regain the confidence of high-end consumers [17].

Core Viewpoint - The company, Yong'an Pharmaceutical, is currently facing a significant event as its actual controller and chairman, Chen Yong, has been placed under investigation and detention by the local authorities, which may impact the company's governance and operations [1][5]. Group 1: Company Background and Structure - Yong'an Pharmaceutical was established in 2001 and went public in March 2010. The company primarily engages in three business segments: research, production, and sales of taurine products; health food; and special dietary foods (creatine) [5]. - The company has a well-established governance structure and internal control mechanisms, ensuring compliance with relevant laws and regulations [5]. Group 2: Recent Financial Performance - In the first quarter of the year, the company reported revenue of 171 million yuan, a year-on-year decrease of 12.96%. The net loss attributable to the parent company was 4.37 million yuan, a decline of 115.23% compared to the previous year [5]. Group 3: Stock Market Activity - Prior to the May Day holiday, Yong'an Pharmaceutical's stock experienced significant volatility, achieving five consecutive daily price increases from April 21 to April 29, with a total increase of nearly 60% during this period [4][5]. - On April 30, the stock closed at a limit down price of 12.91 yuan per share, with a market capitalization of 3.8 billion yuan [6].

Group 1: Market Supervision and Compliance - The market supervision authority conducted a routine inspection of the company "胖东来唯初珠宝有限公司" regarding its sales of Hetian jade during the first four months of 2025, following public concerns raised online [2][4] - The company sold a total of 4,177 pieces of Hetian jade with a sales amount of 29.592175 million yuan, achieving an average gross profit margin of no more than 20% [4] - All currently sold Hetian jade products are clearly priced, and the randomly checked 13 items had complete purchase documentation and valid certification from accredited institutions [4] Group 2: Legal Actions and Public Relations - Following allegations from social media influencer "柴怼怼" regarding the company's pricing and product quality, the company issued a response and has initiated legal proceedings for defamation against the influencer [4] - The company filed a lawsuit on April 25, 2025, in the Intermediate People's Court of Xuchang regarding the defamation claims [4] Group 3: Industry Trends and Stock Market Movements - The stock market saw a decline with the S&P 500 ending a nine-day rally, influenced by significant drops in major tech stocks, including a more than 5% drop in Berkshire Hathaway [8][9] - The international oil prices weakened, with West Texas Intermediate crude oil falling by 1.82% to $57.23 per barrel, while Brent crude oil dropped by 1.55% to $60.34 per barrel [11] - In contrast, international gold prices surged, with spot gold rising by 2.85% to $3,332.85 per ounce [11] Group 4: Film Industry Insights - The box office for the 2025 May Day holiday period reached 744 million yuan, with the top three films being "水饺皇后," "猎金·游戏," and "幽灵公主" [17][18] - The film "水饺皇后" generated the highest revenue of approximately 191.5 million yuan, accounting for 25.7% of the total box office [20]

但在易主的首年，万达电影的成绩单却难言乐观——近日，万达电影发布的财报显示， 2024 年，其不仅营收同比下滑，归母净利润更是由盈转亏，亏损额达 9.4 亿元。公司最核 心的观影业务毛利率由正转负，每卖出一张电影票毛利亏损至少 4 元。这些业绩表现不仅 反映了去年行业整体低迷的行情，也折射出控制权变更过程中的过渡期阵痛。 值得注意的是，尽管业绩面临压力， 2024 年万达电影董事和高级管理人员获得的税前报 酬总额却同比增加 54% 至 3495.75 万元。其中，新任董事长陈曦以 1017.25 万元年薪 位居榜首。万达系高管薪酬普遍下调，例如执行总裁陈洪涛虽然以 763.91 万元紧随陈曦 其后，但其年薪较 2023 年的 923.12 万元减少近 160 万元。 卖票倒贴钱？ 观影业务毛利转负 财报数据显示， 2024 年，万达电影营收 123.62 亿元，较 2023 年的 146.18 亿元下降 15.44% 。盈利方面，归母净利润由 2023 年的 9.12 亿元骤降至 2024 年的亏损 9.4 亿 元，扣非归母净利润同样不容乐观，从 2023 年的盈利 7.18 亿元降至 2024 年的亏损 1 ...

据报道，上述论文2017年6月发布在《实用妇科内分泌》电子杂志，在线公开时间为2017 年11月29日，作者为山东大学齐鲁医院妇科霍文静。 下载论文后可以看到，论文的资料与方法中介绍称："选取本院2015年4月-2016年4月收 治的接受手术治疗的子宫肌瘤患者80例，分为观察组和对照组，每组40例。对照组患者 中，男27例，女13例，观察组患者中，男28例，女12例，年龄24-55岁，平均年龄 （42.5±3.2）岁。"而在该论文的开头部分，则称"子宫肌瘤是女性常见的良性肿瘤之一"。 近日，一篇题为《针对性护理干预在子宫肌瘤围手术期的情绪和生活质量临床应用效果》的 论文 ，被网友广泛议论。论文称"选取了子宫肌瘤患者80例，对照组患者中，男27例，女 13例，观察组患者中，男28例，女12例"。 男性会患子宫肌瘤吗？ 该论文被指"过于离 谱"。 有媒体报道称，某三甲医院妇产科医生表示， 针对子宫肌瘤的研究，对照观察组病例中不 可能包括男性患者 ，"这种情况可以举报学术不端，但凡经过外审的论文都不会发生这种错 误。" 5月5日下午，@山东大学齐鲁医院 官方微博发布情况说明称：5月5日上午，我院关注到网 友反馈的相 ...